BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33638417)

  • 1. Continuous capture scale down model: A comparison of a continuous and a discrete approach.
    Seidel JC; Göbel M; Dos Reis Rodrigues RC; Kaup NM; Rapp J; Frauenschuh A; Shultz J; Cui H
    Biotechnol Bioeng; 2021 Sep; 118(9):3375-3381. PubMed ID: 33638417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer of a three step mAb chromatography process from batch to continuous: Optimizing productivity to minimize consumable requirements.
    Gjoka X; Gantier R; Schofield M
    J Biotechnol; 2017 Jan; 242():11-18. PubMed ID: 27939321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-scale quality assessment of a mechanistic cation exchange chromatography model.
    Saleh D; Wang G; Mueller B; Rischawy F; Kluters S; Studts J; Hubbuch J
    Biotechnol Prog; 2021 Jan; 37(1):e3081. PubMed ID: 32926575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale monoclonal antibody purification by continuous chromatography, from process design to scale-up.
    Girard V; Hilbold NJ; Ng CK; Pegon L; Chahim W; Rousset F; Monchois V
    J Biotechnol; 2015 Nov; 213():65-73. PubMed ID: 25962790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periodic counter-current chromatography -- design and operational considerations for integrated and continuous purification of proteins.
    Godawat R; Brower K; Jain S; Konstantinov K; Riske F; Warikoo V
    Biotechnol J; 2012 Dec; 7(12):1496-508. PubMed ID: 23070975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of using continuous chromatography in downstream processing: Comparison of costs and product quality for a hybrid process vs. a conventional batch process.
    Ötes O; Flato H; Winderl J; Hubbuch J; Capito F
    J Biotechnol; 2017 Oct; 259():213-220. PubMed ID: 28684321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing protein A productivity and resin utilization within integrated or intensified processes.
    Brinkmann A; Elouafiq S
    Biotechnol Bioeng; 2021 Sep; 118(9):3359-3366. PubMed ID: 33638385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new, integrated, continuous purification process template for monoclonal antibodies: Process modeling and cost of goods studies.
    Xenopoulos A
    J Biotechnol; 2015 Nov; 213():42-53. PubMed ID: 25959171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated continuous production of recombinant therapeutic proteins.
    Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
    Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and operation of a continuous integrated monoclonal antibody production process.
    Steinebach F; Ulmer N; Wolf M; Decker L; Schneider V; Wälchli R; Karst D; Souquet J; Morbidelli M
    Biotechnol Prog; 2017 Sep; 33(5):1303-1313. PubMed ID: 28691347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Raman spectroscopy in monoclonal antibody producing continuous systems for downstream process intensification.
    Yilmaz D; Mehdizadeh H; Navarro D; Shehzad A; O'Connor M; McCormick P
    Biotechnol Prog; 2020 May; 36(3):e2947. PubMed ID: 31837253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery and purification process development for monoclonal antibody production.
    Liu HF; Ma J; Winter C; Bayer R
    MAbs; 2010; 2(5):480-99. PubMed ID: 20647768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scale-up of continuous multicolumn chromatography for the protein a capture step: From bench to clinical manufacturing.
    Ötes O; Flato H; Vazquez Ramirez D; Badertscher B; Bisschops M; Capito F
    J Biotechnol; 2018 Sep; 281():168-174. PubMed ID: 30025795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for Comparison of Productivity Between Fed-Batch and Perfusion Processes.
    Bausch M; Schultheiss C; Sieck JB
    Biotechnol J; 2019 Feb; 14(2):e1700721. PubMed ID: 30024096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the Downstream Processing of Monoclonal Antibodies Reveals Cost Advantages for Continuous Methods for a Broad Range of Manufacturing Scales.
    Hummel J; Pagkaliwangan M; Gjoka X; Davidovits T; Stock R; Ransohoff T; Gantier R; Schofield M
    Biotechnol J; 2019 Feb; 14(2):e1700665. PubMed ID: 29341493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous integrated antibody precipitation with two-stage tangential flow microfiltration enables constant mass flow.
    Burgstaller D; Jungbauer A; Satzer P
    Biotechnol Bioeng; 2019 May; 116(5):1053-1065. PubMed ID: 30636284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The design basis for the integrated and continuous biomanufacturing framework.
    Coffman J; Bibbo K; Brower M; Forbes R; Guros N; Horowski B; Lu R; Mahajan R; Patil U; Rose S; Shultz J
    Biotechnol Bioeng; 2021 Sep; 118(9):3323-3333. PubMed ID: 33522595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving an intensified and integrated continuous bioprocess platform for biologics manufacturing.
    Zhou H; Fang M; Zheng X; Zhou W
    Biotechnol Bioeng; 2021 Sep; 118(9):3618-3623. PubMed ID: 33788278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved protein A resin for antibody capture in a continuous countercurrent tangential chromatography system.
    Fedorenko D; Dutta AK; Tan J; Walko J; Brower M; Pinto NDS; Zydney AL; Shinkazh O
    Biotechnol Bioeng; 2020 Mar; 117(3):646-653. PubMed ID: 31784975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choices of capture chromatography technology in antibody manufacturing processes.
    DiLeo M; Ley A; Nixon AE; Chen J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():136-148. PubMed ID: 29069629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.